Pediatric electrophysiology is an invaluable part of any healthcare system, and its importance is only growing as technologies continue to evolve. We spoke to Nicholas Von Bergen, MD, to learn more...

A variety of CPT code changes take effect in 2026, and many of them will make a direct impact on interventional cardiology. Arnold Seto, MD, spoke to Cardiovascular Business about these updates for a...

New two-year data confirm that the IVL technology developed by Shockwave Medical can be used to treat diabetic patients who require PCI.

Listen in to this webinar to gain a deeper understanding of updates to coding and billing for Barostim that are effective on January 1, 2026. We'll cover coding and billing specifics for hospitals,...

Mitral valve surgery can be especially challenging when patients present with a small mitral valve area. When it comes to M-TEER, however, treatment still appears to be both safe and effective.

The device, currently just a prototype, could be the first of its kind to gain FDA approval.

According to a new study of nearly 7,000 patients, type 1 and type 2 diabetes are both linked to significantly shorter life expectancies. The risk of sudden cardiac death appears to be highest for...

Interventional cardiology's second Match Day was a significant success. Due to a lack of candidates, however, dozens of fellowship positions remain unfilled. 

While patients with a weakened immune system are still more likely to die after TAVR than other patients, those deaths are largely not related to the procedure or any other cardiovascular issues....

Listen in to this webinar to gain a deeper understanding of updates to coding and billing for Barostim that are effective on January 1, 2026. We'll cover coding and billing specifics for hospitals,...

The company expects TAVR sales alone to be as high as $4.9 billion in 2026. Other minimally invasive therapies are projected to make a major impact as well.

The allegation came days after an internal FDA memo linked the vaccines to the deaths of multiple children. A group of former FDA commissioners pushed back against the content of that memo.

Pope Leo XIV told interventional cardiologists their work “stands at the crossroads of science, compassion and ethical responsibility.” When they treat patients, he added, they are treating the heart...

The Hotwire Transseptal Access System includes the Hotwire RF Generator and Hotwire RF Guidewire, giving electrophysiologists the tools they need for left-heart access. 

Two of the world's leading healthcare companies have partnered on a new treatment option for patients with type 1 diabetes.

All 15 members of the FDA's Circulatory System Devices Panel agreed that more data is required to confirm the new device from Johnson & Johnson MedTech is effective. Will the agency agree with these...

SCAI and CRT have announced a new partnership focused on education, advocacy and research.

Listen in to this webinar to gain a deeper understanding of updates to coding and billing for Barostim that are effective on January 1, 2026. We'll cover coding and billing specifics for hospitals,...

The sensor-guided device delivers continuous hemodynamic measurements and rapid left ventricular pacing during TAVR procedures. Back in 2023, it was at the heart of a $253 million acquisition. 

Hemostemix believes its new cell therapy platform can help treat peripheral artery disease, congestive heart failure, cardiomyopathy and other serious medical conditions. The company plans on...